100 GENES FOUNDi

Show / hide columns »

XML | RDF | TAB | « prev | Page of 2

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KCNK1Potassium channel, two pore domain subfamily K, member 1Predicted membrane proteins
Voltage-gated ion channels
VesiclesMixed
KCNK13Potassium channel, two pore domain subfamily K, member 13Predicted membrane proteins
Voltage-gated ion channels
Nuclear speckles
Cell Junctions
Tissue enhanced
KCNK15Potassium channel, two pore domain subfamily K, member 15Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK17Potassium channel, two pore domain subfamily K, member 17Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK18Potassium channel, two pore domain subfamily K, member 18Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNK2Potassium channel, two pore domain subfamily K, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Mitochondria
Cytosol
Tissue enhanced
KCNK5Potassium channel, two pore domain subfamily K, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
NucleusTissue enhanced
KCNK6Potassium channel, two pore domain subfamily K, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Actin filaments
Cytosol
Mixed
KCNK7Potassium channel, two pore domain subfamily K, member 7Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Voltage-gated ion channels
Plasma membraneTissue enriched
KCNMA1Potassium channel, calcium activated large conductance subfamily M alpha, member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN1Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Actin filaments
Cytosol
Tissue enriched
KCNN2Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Cytosol
Tissue enhanced
KCNN3Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3Predicted membrane proteins
Voltage-gated ion channels
NucleoplasmTissue enhanced
KCNN4Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium channel, voltage gated KQT-like subfamily Q, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium channel, voltage gated KQT-like subfamily Q, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ4Potassium channel, voltage gated KQT-like subfamily Q, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNQ5Potassium channel, voltage gated KQT-like subfamily Q, member 5Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
VesiclesTissue enhanced
KCNS2Potassium voltage-gated channel, modifier subfamily S, member 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS3Potassium voltage-gated channel, modifier subfamily S, member 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatus
Plasma membrane
Cytosol
Tissue enhanced
KCNT1Potassium channel, sodium activated subfamily T, member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNT2Potassium channel, sodium activated subfamily T, member 2Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enhanced
KCNV2Potassium channel, voltage gated modifier subfamily V, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
MCOLN1Mucolipin 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Cytosol
Expressed in all
MCOLN2Mucolipin 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Intermediate filamentsMixed
MCOLN3Mucolipin 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoli
Cytosol
Tissue enhanced
PKD2Polycystic kidney disease 2 (autosomal dominant)Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumExpressed in all
PKD2L1Polycystic kidney disease 2-like 1Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
PKD2L2Polycystic kidney disease 2-like 2Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Cytosol
Tissue enriched
SCN11ASodium channel, voltage gated, type XI alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
SCN1ASodium channel, voltage gated, type I alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Nuclear bodies
Plasma membrane
Tissue enhanced
SCN2ASodium channel, voltage gated, type II alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN3ASodium channel, voltage gated, type III alpha subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
SCN4ASodium channel, voltage gated, type IV alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Microtubule organizing center
Group enriched
SCN8ASodium channel, voltage gated, type VIII alpha subunitDisease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Vesicles
Cell Junctions
Tissue enriched
SCN9ASodium channel, voltage gated, type IX alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Actin filaments
Focal adhesion sites
Tissue enhanced
TPCN1Two pore segment channel 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
TPCN2Two pore segment channel 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
NucleoliMixed
TRPA1Transient receptor potential cation channel, subfamily A, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPC1Transient receptor potential cation channel, subfamily C, member 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesMixed
TRPC3Transient receptor potential cation channel, subfamily C, member 3Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPC6Transient receptor potential cation channel, subfamily C, member 6Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Cytosol
Tissue enhanced
TRPC7Transient receptor potential cation channel, subfamily C, member 7Predicted membrane proteins
Voltage-gated ion channels
Actin filaments
Focal adhesion sites
Not detected
TRPM1Transient receptor potential cation channel, subfamily M, member 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Cytosol
Group enriched
TRPM4Transient receptor potential cation channel, subfamily M, member 4Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Plasma membrane
Mixed
TRPM5Transient receptor potential cation channel, subfamily M, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
TRPM7Transient receptor potential cation channel, subfamily M, member 7Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
NucleoplasmTissue enriched
TRPV4Transient receptor potential cation channel, subfamily V, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Mixed
TRPV5Transient receptor potential cation channel, subfamily V, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Not detected
TRPV6Transient receptor potential cation channel, subfamily V, member 6Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced

« prev | Page of 2